There are limited in-vivo studies of CXCL11 functions, but studies have found elevated levels in patients with autoimmune disease [49, 50] and high levels of all three IFN-γ inducible chemokines have been associated with a poor prognosis in many types of cancers [51]. The gene discussed is CXCL11; the disease is cancer.